Loading
TT
Tryp Therapeutics Inc. Stock: price and insider trades · Canada
Tryp Therapeutics Inc.: what insiders have been doing
Every trade that managers of Tryp Therapeutics Inc. disclose to SEDI is tracked on this page. No insider at Tryp Therapeutics Inc. has published a filing in the past twelve months. The most recent one dates from 3 November 2023.
Our records for Tryp Therapeutics Inc. go back to 2020, with 24 purchases and no sales on the open market in total.
This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Insider Decl.
52
Thresholds
n/a
Buy Volume
€3M
24 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
Last declaration on 3 November 2023
Declarations52 total
2,000,000 shares@ CA$0.108OptionsTSXSEDI:4203976
750,000 shares@ CA$0.108OptionsTSXSEDI:4203974
32,500 shares@ CA$0.158845.4% of flowCommon SharesTSXSEDI:4021278
Canonical exit: 9 Jan 2023 (T+90)
191 shares@ CA$0.1750.3% of flowCommon SharesTSXSEDI:4021280
Canonical exit: 17 Jan 2023 (T+90)
38,738 shares@ CA$0.1654.3% of flowCommon SharesTSXSEDI:4021279
Canonical exit: 17 Jan 2023 (T+90)
OptionsTSXSEDI:3966104
800,000 shares@ CA$0.17100.0% of flowOptionsTSXSEDI:3963691
OptionsTSXSEDI:3963690
800,000 shares@ CA$0.1715.4% of flowOptionsTSXSEDI:3950545
800,000 shares@ CA$0.1720.0% of flowOptionsTSXSEDI:3950542
200,000 shares@ CA$0.1733.5% of flowOptionsTSXSEDI:3950544
200,000 sharesOptionsTSXSEDI:3936052
800,000 sharesOptionsTSXSEDI:3936051
800,000 sharesOptionsTSXSEDI:3936049
OptionsTSXSEDI:3935649
800,000 shares@ CA$0.1719.9% of flowOptionsTSXSEDI:3935646
400,000 shares@ CA$0.1766.5% of flowOptionsTSXSEDI:3935652
800,000 shares@ CA$0.17100.0% of flowOptionsTSXSEDI:3935650
1,000,000 shares@ CA$0.17100.0% of flowOptionsTSXSEDI:3935654
2,000,000 shares@ CA$0.1738.2% of flowOptionsTSXSEDI:3935645
20,000,000 shares@ CA$0.1574.7% of flowCommon SharesTSXSEDI:3935624
Canonical exit: 21 Jul 2022 (T+90)
5,000,000 shares@ CA$0.2093.0% of flowCommon SharesTSXSEDI:3888966
Canonical exit: 23 May 2022 (T+90)
20,000 shares@ CA$0.286578.9% of flowCommon SharesTSXSEDI:3822084
Canonical exit: 24 Jan 2022 (T+90)
5,000 shares@ CA$0.306821.1% of flowCommon SharesTSXSEDI:3822252
Canonical exit: 23 Jan 2022 (T+90)
600,000 shares@ CA$0.75100.0% of flowOptionsTSXSEDI:3796739
25 of 52 declarations
About Tryp Therapeutics Inc.
Tryp Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for mental health disorders and chronic pain. It concentrates on the use of psilocybin and other psychedelic compounds in its research.
